Analyze Diet

Topic:Drug

The topic of drugs and horses encompasses the study of various pharmacological agents used in equine medicine for therapeutic purposes. This includes the administration of medications for pain management, disease treatment, and performance enhancement. The pharmacokinetics and pharmacodynamics of drugs in horses are key areas of research, as they determine the absorption, distribution, metabolism, and excretion of these substances. Additionally, the topic covers the detection and regulation of substances in competitive equestrian sports to ensure fair play and animal welfare. This page compiles peer-reviewed research studies and scholarly articles that explore the effects, safety, and regulatory aspects of drug use in equine health and performance.
Multi-drug-resistant Enterococcus spp. as a cause of non-responsive septic synovitis in three horses.
New Zealand veterinary journal    April 16, 2012   Volume 60, Issue 5 297-304 doi: 10.1080/00480169.2011.651702
Herdan CL, Acke E, Dicken M, Archer RM, Forsyth SF, Gee EK, Pauwels FE.Three Thoroughbred horses, a 6-week-old filly (Case 1), a 15-year-old broodmare (Case 2) and a yearling filly (Case 3), sustained synovial sepsis secondary to trauma. Results: Case 1 presented with a heel bulb laceration communicating with the distal interphalangeal joint. Arthroscopic lavage was performed and treatment commenced using systemic and local broad spectrum antimicrobial drugs. A pure growth of multi-drug-resistant (MDR) Enterococcus gallinarum was cultured from samples of synovium and joint fluid. Antimicrobial treatment was changed according to the susceptibility results. Respons...
Pharmacokinetics of stanozolol in Thoroughbred horses following intramuscular administration.
Journal of veterinary pharmacology and therapeutics    April 11, 2012   Volume 36, Issue 2 201-204 doi: 10.1111/j.1365-2885.2012.01393.x
Moeller BC, Sams RA, Guingab-Cagmat JD, Szabo NJ, Colahan P, Stanley SD.No abstract available
Comparison of continuous infusion with intermittent bolus administration of cefotaxime on blood and cavity fluid drug concentrations in neonatal foals.
Journal of veterinary pharmacology and therapeutics    April 11, 2012   Volume 36, Issue 1 68-77 doi: 10.1111/j.1365-2885.2012.01394.x
Hewson J, Johnson R, Arroyo LG, Diaz-Mendez A, Ruiz-López JA, Gu Y, del Castillo JR.Healthy neonatal foals were treated with cefotaxime by bolus (40 mg/kg i.v. q6h for 12 doses; n=10) or by infusion (loading dose of 40 mg/kg i.v. followed by continuous infusion of a total daily dose of 160 mg/kg per 24 h for 3 days; n=5). Population pharmacokinetics was determined, and concentrations in cavity fluids were measured at steady state (72 h). Highest measured serum drug concentration in the bolus group was 88.09 μg/mL and minimum drug concentration (C(min)) was 0.78 μg/mL at 6-h postadministration (immediately before each next dose), whereas infusion resulted in a steady-state c...
Efficacy of major anthelmintics against horse cyathostomins in France.
Veterinary parasitology    April 3, 2012   Volume 188, Issue 3-4 294-300 doi: 10.1016/j.vetpar.2012.03.048
Traversa D, Castagna G, von Samson-Himmelstjerna G, Meloni S, Bartolini R, Geurden T, Pearce MC, Woringer E, Besognet B, Milillo P, D'Espois M.This paper reports a survey conducted in France during 2011 to evaluate the efficacy of commonly used anthelmintics against horse cyathostomins. A total of 40 farms and 1089 horses were screened for the presence of cyathostomins. All farms but one were positive, with an overall animal infection rate of 53.7%, ranging from 9% to 83% on individual farms. On 445 horses from 30 of these farms, a faecal egg count reduction test (FECRT) was performed to evaluate the efficacy of oral formulations of fenbendazole (FBZ), pyrantel embonate (PYR), ivermectin (IVM) and moxidectin (MOX). Calculation of the...
A new analytical method based on anti-EPO monolith column and LC-FAIMS-MS/MS for the detection of rHuEPOs in horse plasma and urine samples.
The Analyst    March 27, 2012   Volume 137, Issue 10 2445-2453 doi: 10.1039/c2an15662h
Bailly-Chouriberry L, Cormant F, Garcia P, Lönnberg M, Szwandt S, Bondesson U, Popot MA, Bonnaire Y.Recombinant human erythropoietin (rHuEPO) is a 30-34 kDa glycoprotein banned by the racing authorities. For some years this molecule has been detected in race horses in USA and in Europe, and even in racing camels. Although direct methods to differentiate horse endogenous EPO and rHuEPO have been developed either by LC-MS/MS or by isoelectric focusing (IEF) with double-blotting, the short confirmation time of such prohibited hormone in plasma remains a problem for horseracing doping control laboratories. In order to improve the rHuEPOs confirmation process in horse plasma or urine in terms of ...
Antimicrobial drug concentrations and sampling techniques in the equine lung.
Veterinary journal (London, England : 1997)    March 25, 2012   Volume 193, Issue 2 326-335 doi: 10.1016/j.tvjl.2012.02.010
Winther L.The distribution of antimicrobial drugs in the equine lung is important in designing optimal dosage regimens for the treatment of lower airway infections. Several studies in horses and other species have shown that the pharmacokinetics of a drug in the lung cannot necessarily be predicted by its behaviour in plasma, and influencing factors include the class of drug, the animal species and the chosen sampling technique. This review provides a description of the target site for bacterial lower airway infections and describes the penetration of antibiotics into lung matrices. It also offers an ov...
Towards an inhalative in vivo application of immunomodulating gelatin nanoparticles in horse-related preformulation studies.
Journal of microencapsulation    March 20, 2012   Volume 29, Issue 7 615-625 doi: 10.3109/02652048.2012.668962
Fuchs S, Klier J, May A, Winter G, Coester C, Gehlen H.Delivering active ingredients using biocompatible and biodegradable carriers such as gelatin nanoparticles (GNPs) to the lung constitutes a promising non-invasive route of administration. However, the pulmonary delivery of nanoparticle-based immunotherapy is still a field that requires more clarification. In this study, GNPs loaded with cytosine-phosphate-guanine oligodeoxynucleotides (CpG-ODN)-loaded and plain GNPs were aerosolised either by a conventional pressured metered dose inhaler (pMDI) or by active or passive vibrating-mesh (VM) nebulisers. GNP sizes after nebulisation by active and p...
Pyrethroid tolerance in the chewing louse Bovicola (Werneckiella) ocellatus.
Veterinary parasitology    March 20, 2012   Volume 188, Issue 1-2 134-139 doi: 10.1016/j.vetpar.2012.03.018
Ellse L, Burden F, Wall R.Equine pediculosis is a significant health and welfare issue, particularly in elderly and chronically debilitated animals. Currently infestation is controlled predominantly using topically applied pyrethroid insecticides, allowing limited scope for the rotation of drugs and increasing the risk of selection for resistance. Here the insecticidal efficacies of two pyrethroid-based products against the louse Bovicola (Werneckiella) ocellatus collected from donkeys were examined in vitro. The products were cypermethrin (Deosect™, Pfizer Ltd., 5% (w/v) cypermethrin, cutaneous spray) and permethrin...
The effect of P-glycoprotein on methadone hydrochloride flux in equine intestinal mucosa.
Journal of veterinary pharmacology and therapeutics    March 19, 2012   Volume 36, Issue 1 43-50 doi: 10.1111/j.1365-2885.2012.01390.x
Linardi RL, Stokes AM, Andrews FM.Methadone is an effective analgesic opioid that may have a place for the treatment of pain in horses. However, its absorption seems to be impaired by the presence of a transmembrane protein, P-glycoprotein, present in different tissues including the small intestine in other species. This study aims to determine the effect of the P-glycoprotein on methadone flux in the equine intestinal mucosa, as an indicator of in vivo drug absorption. Jejunum tissues from five horses were placed into the Ussing chambers and exposed to methadone solution in the presence or absence of Rhodamine 123 or verapami...
Prevalence of Parascaris equorum infection in foals on French stud farms and first report of ivermectin-resistant P. equorum populations in France.
Veterinary parasitology    March 9, 2012   Volume 188, Issue 1-2 185-189 doi: 10.1016/j.vetpar.2012.02.022
Laugier C, Sevin C, Ménard S, Maillard K.No abstract available
Medetomidine continuous rate intravenous infusion in horses in which surgical anaesthesia is maintained with isoflurane and intravenous infusions of lidocaine and ketamine.
Veterinary anaesthesia and analgesia    March 8, 2012   Volume 39, Issue 3 245-255 doi: 10.1111/j.1467-2995.2011.00701.x
Kempchen S, Kuhn M, Spadavecchia C, Levionnois OL.To evaluate medetomidine as a continuous rate infusion (CRI) in horses in which anaesthesia is maintained with isoflurane and CRIs of ketamine and lidocaine. Methods: Prospective, randomized, blinded clinical trial. Methods: Forty horses undergoing elective surgery. Methods: After sedation and induction, anaesthesia was maintained with isoflurane. Mechanical ventilation was employed. All horses received lidocaine (1.5 mg kg(-1) initially, then 2 mg kg(-1) hour(-1)) and ketamine (2 mg kg(-1) hour(-1)), both CRIs reducing to 1.5 mg kg(-1) hour(-1) after 50 minutes. Horses in group MILK received ...
The effects of yohimbine on the pharmacokinetic parameters of detomidine in the horse.
Veterinary anaesthesia and analgesia    March 8, 2012   Volume 39, Issue 3 221-229 doi: 10.1111/j.1467-2995.2011.00690.x
Knych HK, Steffey EP, Stanley SD.To describe the pharmacokinetics of detomidine and yohimbine when administered in combination. Methods: Randomized crossover design. Methods: Nine healthy adult horses aged 9 ± 4 years and weighing of 561 ± 56 kg. Methods: Three dose regimens were employed in the current study. 1) 0.03 mg kg(-1) detomidine IV (D), 2) 0.2 mg kg(-1) yohimbine IV (Y) and 3) 0.03 mg kg(-1) detomidine IV followed 15 minutes later by 0.2 mg kg(-1) yohimbine IV (DY). Each horse received all three dose regimens with a minimum of 1 week in between subsequent regimens. Blood samples were obtained and plasma analyzed f...
Antinociceptive effects of low dose lumbosacral epidural ropivacaine in healthy ponies.
Veterinary journal (London, England : 1997)    March 6, 2012   Volume 193, Issue 1 240-245 doi: 10.1016/j.tvjl.2011.11.004
van Loon JP, Menke ES, Doornenbal A, Back W, Hellebrekers LJ.The objective of this study was to evaluate the safety and efficacy of low dose lumbosacral epidural ropivacaine in ponies. Antinociceptive effects of epidural ropivacaine were evaluated by means of mechanical nociceptive thresholds (MNTs) at several spinal levels in conscious ponies. The effects of ropivacaine on nociceptive afferent transmission to the spinal cord were also assessed by measuring spinal cord somatosensory evoked potentials (SSEPs) in anaesthetised ponies. Ataxia scores were determined in conscious ponies to assess the effects on motor function. A randomised, placebo controlle...
Detection of myo-inositol trispyrophosphate in equine urine and plasma by hydrophillic interaction chromatography-tandem mass spectrometry.
Drug testing and analysis    February 22, 2012   Volume 4, Issue 5 355-361 doi: 10.1002/dta.397
Wong AS, Ho EN, Wan TS.Myo-inositol trispyrophosphate (ITPP) is a new drug capable of increasing the amount of oxygen in hypoxic tissues. Studies have shown that administration of ITPP increases the maximal exercise capacity in normal mice as well as mice with severe heart failure. The properties of ITPP make it an ideal candidate as a doping agent to enhance performance in racehorses. While there have been speculations in the horseracing industry that the covert use of ITPP is already widespread, no reported method exists for the detection of ITPP in equine biological samples. ITPP is a difficult-to-detect drug due...
Pharmacokinetics and pharmacodynamics of butorphanol following intravenous administration to the horse.
Journal of veterinary pharmacology and therapeutics    February 20, 2012   Volume 36, Issue 1 21-30 doi: 10.1111/j.1365-2885.2012.01385.x
Knych HK, Casbeer HC, McKemie DS, Arthur RM.Butorphanol is a narcotic analgesic commonly used in horses. Currently, any detectable concentration of butorphanol in biological samples collected from performance horses is considered a violation. The primary goal of the study reported here was to update the pharmacokinetics of butorphanol following intravenous administration, utilizing a highly sensitive liquid chromatography-mass spectrometry (LC-MS) assay that is currently employed in many drug-testing laboratories. An additional objective was to characterize behavioral and cardiac effects following administration of butorphanol. Ten exer...
Regulatory control of glycopyrrolate in performance horses using validated UHPLC/MS-MS methods.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences    February 13, 2012   Volume 889-890 130-137 doi: 10.1016/j.jchromb.2012.02.008
Rumpler MJ, Sams RA, Colahan P.We describe a validated, rapid, sensitive, and specific UHPLC-MS/MS method to detect and quantify glycopyrrolate in 0.5 mL of horse urine. Further, we investigated the elimination of glycopyrrolate in urine after both intravenous and oral administration of clinically relevant doses to Thoroughbred horses. Quantification was performed by weighted, linear regression analysis using a deuterated analogue of glycopyrrolate as internal standard (IS). The method was characterized by a linear range of 5-2500 pg/mL, a lower limit of quantification of 5 pg/mL and a limit of detection of 1 pg/mL. The int...
Bioavailability and pharmacokinetics of oral and injectable formulations of methadone after intravenous, oral, and intragastric administration in horses.
American journal of veterinary research    January 28, 2012   Volume 73, Issue 2 290-295 doi: 10.2460/ajvr.73.2.290
Linardi RL, Stokes AM, Keowen ML, Barker SA, Hosgood GL, Short CR.To characterize the bioavailability and pharmacokinetics of oral and injectable formulations of methadone after IV, oral, and intragastric administration in horses. Methods: 6 healthy adult horses. Methods: Horses received single doses (each 0.15 mg/kg) of an oral formulation of methadone hydrochloride orally or intragastrically or an injectable formulation of the drug orally, intragastrically, or IV (5 experimental treatments/horse; 2-week washout period between each experimental treatment). A blood sample was collected from each horse before and at predetermined time points over a 360-minute...
Pharmacokinetics of firocoxib and its interaction with enrofloxacin in horses.
Journal of veterinary pharmacology and therapeutics    January 11, 2012   Volume 35, Issue 6 615-617 doi: 10.1111/j.1365-2885.2011.01362.x
Cox S, Dudenbostel L, Sommardahl C, Yarbrough J, Saleh M, Doherty T.No abstract available
Pharmacokinetic profile and pharmacodynamic effects of romifidine hydrochloride in the horse.
Journal of veterinary pharmacology and therapeutics    January 11, 2012   Volume 35, Issue 5 478-488 doi: 10.1111/j.1365-2885.2011.01347.x
Wojtasiak-Wypart M, Soma LR, Rudy JA, Uboh CE, Boston RC, Driessen B.Romifidine HCl (romifidine) is an α(2)-agonist commonly used in horses. This study was undertaken to investigate the pharmacokinetics (PK) of romifidine following intravenous (i.v.) administration and describe the relationship between PK parameters and simultaneously recorded pharmacodynamic (PD) parameters. Romifidine (80 μg/kg) was administered by i.v. infusion over 2 min to six adult Thoroughbred horses, and plasma samples were collected and analyzed using liquid chromatography-mass spectrometry. Limit of quantification was <0.1 ng/mL. PD parameters and arterial blood gases were measur...
Rapid screening of anabolic steroids in horse urine with ultra-high-performance liquid chromatography/tandem mass spectrometry after chemical derivatisation.
Journal of chromatography. A    January 10, 2012   Volume 1232 257-265 doi: 10.1016/j.chroma.2011.12.095
Wong CH, Leung DK, Tang FP, Wong JK, Yu NH, Wan TS.Liquid chromatography/mass spectrometry (LC/MS) has been successfully applied to the detection of anabolic steroids in biological samples. However, the sensitive detection of saturated hydroxysteroids, such as androstanediols, by electrospray ionisation (ESI) is difficult because of their poor ability to ionise. In view of this, chemical derivatisation has been used to enhance the detection sensitivity of hydroxysteroids by LC/MS. This paper describes the development of a sensitive ultra-high-performance liquid chromatography/tandem mass spectrometry (UHPLC/MS/MS) method for the screening of a...
In vitro potential of equine DEFA1 and eCATH1 as alternative antimicrobial drugs in rhodococcosis treatment.
Antimicrobial agents and chemotherapy    January 9, 2012   Volume 56, Issue 4 1749-1755 doi: 10.1128/AAC.05797-11
Schlusselhuber M, Jung S, Bruhn O, Goux D, Leippe M, Leclercq R, Laugier C, Grötzinger J, Cauchard J.Rhodococcus equi, the causal agent of rhodococcosis, is a severe pathogen of foals but also of immunodeficient humans, causing bronchopneumonia. The pathogen is often found together with Klebsiella pneumoniae or Streptococcus zooepidemicus in foals. Of great concern is the fact that some R. equi strains are already resistant to commonly used antibiotics. In the present study, we evaluated the in vitro potential of two equine antimicrobial peptides (AMPs), eCATH1 and DEFA1, as new drugs against R. equi and its associated pathogens. The peptides led to growth inhibition and death of R. equi and ...
Effect of prolonged administration of clenbuterol on airway reactivity and sweating in horses with inflammatory airway disease.
American journal of veterinary research    December 30, 2011   Volume 73, Issue 1 140-145 doi: 10.2460/ajvr.73.1.140
Read JR, Boston RC, Abraham G, Bauquier SH, Soma LR, Nolen-Walston RD.To determine whether prolonged administration of clenbuterol results in tachyphylaxis, specifically regarding its bronchoprotective properties and effect on sweating in horses. Methods: 8 Thoroughbreds with inflammatory airway disease. Methods: In a crossover design, horses received clenbuterol (0.8 μg/kg, p.o., q 12 h) or placebo for 21 days, with a washout period of ≥ 30 days between the 2 treatments. Airway reactivity was evaluated by use of flowmetric plethysmography and histamine broncho-provocation before (day 0; baseline) and every 7 days after the start of treatment. Sweat function ...
[New drugs for horses and production animals in 2010].
Tierarztliche Praxis. Ausgabe G, Grosstiere/Nutztiere    December 15, 2011   Volume 39, Issue 6 384-390 
Emmerich IU.In 2010, three new active pharmaceutical ingredients were released on the German market for horses and food-producing animals. These were gamithromycin (Zactran®), a new macrolide antibiotic, Monepantel (Zolvix®), a broad spectrum anthelmintic with a novel mechanism, and Pergolide (Prascend®), the first dopamine receptor agonist for animals. Two substances have been approved for additional species. The tetracycline antibiotic doxycycline is now also authorized for turkeys and the nonsteroidal anti-inflammatory drug firocoxib from the group of cyclo-oxygenase-2 (COX-2) inhibitors is now avai...
Clarithromycin is absorbed by an intestinal uptake mechanism that is sensitive to major inhibition by rifampicin: results of a short-term drug interaction study in foals.
Drug metabolism and disposition: the biological fate of chemicals    December 14, 2011   Volume 40, Issue 3 522-528 doi: 10.1124/dmd.111.042267
Peters J, Eggers K, Oswald S, Block W, Lütjohann D, Lämmer M, Venner M, Siegmund W.Pulmonary penetration of clarithromycin (CLR) in epithelial lining fluid (ELF) and bronchoalveolar lavage cells (BALCs) can be influenced by CYP3A4, by P-glycoprotein, and, according to our hypothesis, by a member of the organic anion-transporting protein (OATP) family, for which rifampicin (RIF) is inhibiting in single doses but inducing after long-term coadministration. To assess the partial inhibitory effect, we measured absorption and pulmonary distribution of CLR after short-term (2.5-day) coadministration of RIF, after which up-regulation is not expected. The drug interaction study was p...
Development of a romifidine constant rate infusion with or without butorphanol for standing sedation of horses.
Veterinary anaesthesia and analgesia    December 14, 2011   Volume 39, Issue 1 12-20 doi: 10.1111/j.1467-2995.2011.00681.x
Ringer SK, Portier KG, Fourel I, Bettschart-Wolfensberger R.To determine constant rate infusion (CRI) protocols for romifidine (R) and romifidine combined with butorphanol (RB) resulting in constant sedation and romifidine plasma concentrations. Methods: Blinded randomized crossover study. Methods: Ten adult research horses. Methods: Part I: After determining normal height of head above ground (HHAG = 100%), loading doses of romifidine (80 μg kg(-1)) with butorphanol (RB: 18 μg kg(-1)) or saline (R) were given intravenously (IV). Immediately afterwards, a butorphanol (RB: 25 μg kg(-1) hour(-1)) or saline (R) CRI was administered for 2 hours. The HHA...
Phenylbutazone and flunixin meglumine used singly or in combination in experimental lameness in horses.
Equine veterinary journal. Supplement    December 7, 2011   Issue 40 12-17 doi: 10.1111/j.2042-3306.2011.00485.x
Foreman JH, Ruemmler R.Using an adjustable heart bar shoe model of foot pain, the objective of this study was to test the hypothesis that the combined use of phenylbutazone (PBZ) and flunixin meglumine (FM) would prove more efficacious in alleviating lameness than either drug alone. Methods: One hour after induction of lameness at weekly intervals, 8 healthy adult Thoroughbred horses randomly underwent one of 4 i.v. treatments: saline (SAL) placebo (1 ml/45 kg bwt), PBZ (4.4 mg/kg bwt), FM (1.1 mg/kg bwt) or PBZ+FM (at the same dosages as given individually). Heart rate (HR) and lameness score (LS) responses were as...
Pharmacokinetics and preliminary safety evaluation of azithromycin in adult horses.
Journal of veterinary pharmacology and therapeutics    December 5, 2011   Volume 35, Issue 6 541-549 doi: 10.1111/j.1365-2885.2011.01351.x
Leclere M, Magdesian KG, Cole CA, Szabo NJ, Ruby RE, Rhodes DM, Edman J, Vale A, Wilson WD, Tell LA.Azithromycin is widely used in foals but has not been studied in adult horses. The goals of this study were to determine the pharmacokinetic profile and to make a preliminary assessment of the safety of azithromycin in adult horses. Azithromycin was administered intravenously (5 mg/kg) and intragastrically (10 mg/kg) to six healthy mares in a crossover design. Serial plasma samples, blood neutrophils, and pulmonary macrophages were collected for the measurement of azithromycin concentrations. Azithromycin was also administered orally (10 mg/kg) once a day for 5 days to five healthy mares for p...
Pharmacokinetics of concurrently administered intravenous lidocaine and flunixin in healthy horses.
Journal of veterinary pharmacology and therapeutics    December 2, 2011   Volume 35, Issue 4 413-416 doi: 10.1111/j.1365-2885.2011.01356.x
Waxman SJ, KuKanich B, Milligan M, Beard WL, Davis EG.No abstract available
Anesthetic induction with guaifenesin and propofol in adult horses.
American journal of veterinary research    December 1, 2011   Volume 72, Issue 12 1569-1575 doi: 10.2460/ajvr.72.12.1569
Brosnan RJ, Steffey EP, Escobar A, Palazoglu M, Fiehn O.To evaluate whether guaifenesin can prevent adverse anesthetic induction events caused by propofol and whether a guaifenesin-propofol induction combination has brief cardiovascular effects commensurate with rapid drug washout. Methods: 8 healthy adult horses. Methods: Guaifenesin was administered IV for 3 minutes followed by IV injection of a bolus of propofol (2 mg/kg). Additional propofol was administered if purposeful movement was detected. Anesthesia was maintained for 2 hours with isoflurane or sevoflurane at 1.2 times the minimum alveolar concentration with controlled normocapnic ventila...
Prolonged neuromuscular blockade in a horse following concomitant use of vecuronium and atracurium.
Veterinary anaesthesia and analgesia    November 25, 2011   Volume 39, Issue 1 119-120 doi: 10.1111/j.1467-2995.2011.00683.x
Gurney M, Mosing M.No abstract available
1 34 35 36 37 38 95